What is the appropriate evaluation and management for a patient who developed neck pain after starting Zepbound (tirzepatide)?

Neck Pain After Starting Zepbound (Tirzepatide)

Neck pain developing after tirzepatide initiation is most likely related to rapid weight loss causing lean-mass depletion, nutritional deficiencies (particularly vitamin E), or musculoskeletal strain from body-composition changes rather than a direct drug effect; continue tirzepatide while implementing high-protein intake (1.2–1.6 g/kg ideal body weight daily), resistance training, comprehensive micronutrient supplementation, and evaluate for peroneal neuropathy or radiculopathy if neurologic symptoms are present. 1

Weight-Loss-Related Musculoskeletal Changes

• Tirzepatide produces 15–20% body weight reduction, with approximately 25% of total weight loss derived from lean mass, predisposing patients to muscle weakness, pain, and altered biomechanics. 1
• Up to 39% of rapid weight loss may be lean-mass loss, which directly contributes to musculoskeletal complaints including neck and back pain. 1
• The mechanical stress from altered posture and muscle imbalances during rapid weight reduction commonly manifests as axial skeletal pain. 1

Nutritional Deficiency Assessment

• Gastrointestinal adverse effects (nausea, vomiting, diarrhea) occur in 25–35% of tirzepatide patients, substantially increasing malabsorption risk and micronutrient deficits. 1
• Vitamin E deficiency is directly linked to peripheral neuropathy; supplementation with 15 mg α-tocopherol daily is recommended for neuropathy prevention. 1
• Fat-soluble vitamin deficiencies (A, D, E, K) are common during aggressive weight-loss regimens that limit dietary fat intake. 1
• Vitamin D (600–800 IU daily) and calcium (1,000–1,200 mg daily in split doses) should be provided to support bone health and muscle function during rapid weight loss. 1
• A daily multivitamin-mineral preparation is advised to offset reduced food intake. 1

Immediate Management Strategy

Continue Tirzepatide

• Mild-to-moderate musculoskeletal symptoms do not require discontinuation of tirzepatide; therapy should be continued with supportive measures. 2
• Hold dose escalation temporarily until nutritional, neurological, and muscular assessments are completed if symptoms are severe or progressive. 1

Implement Lean-Mass Preservation Protocol

• Prescribe 1.2–1.6 g protein per kilogram of ideal body weight daily, distributed as 25–30 g of high-quality protein per meal (lean meats, fish, eggs, dairy, legumes). 1
• Initiate resistance training 2–3 times per week immediately; this is the only intervention proven to actively stimulate muscle protein synthesis and counteract catabolic effects of rapid weight loss. 1
• The American College of Endocrinology endorses beginning resistance training at the start of tirzepatide therapy, not after weight plateau. 1

Micronutrient Supplementation

• Implement a three-pillar strategy: high-protein intake, regular resistance training, and comprehensive micronutrient supplementation to preserve lean mass while maximizing fat loss. 1
• Start vitamin E 15 mg daily, vitamin D 600–800 IU daily, calcium 1,000–1,200 mg daily (split doses), and a daily multivitamin. 1

Neurological Evaluation

• Perform focused physical examination assessing foot dorsiflexion strength, ankle reflexes, sensory perception in the peroneal distribution, and gait to detect peroneal neuropathy. 1
• If peroneal neuropathy is suspected, obtain nerve conduction studies and electromyography. 1
• Reserve lumbar spine MRI for patients with radicular pain patterns (dermatomal distribution, positive straight-leg raise) suggestive of nerve-root compression. 1

Red Flags Requiring Urgent Evaluation

• Evaluate for traumatic injuries, infection, malignancy, vascular emergencies, and inflammatory conditions if neck pain is accompanied by fever, unexplained weight loss beyond expected tirzepatide effect, neurologic deficits, or night pain. 3
• Consider rhabdomyolysis if neck/muscle pain is accompanied by dark urine, severe weakness, or elevated creatine kinase; tirzepatide has been associated with rare cases of severe rhabdomyolysis and necrotizing myopathy. 4

Symptomatic Relief

• Gabapentin may provide short-term relief of neuropathic pain associated with radiculopathy, though it does not address the underlying nutritional or mechanical cause. 1
• Short-term use of NSAIDs or acetaminophen for mechanical neck pain is reasonable while implementing the lean-mass preservation protocol. 3

Monitoring Schedule

• Assess efficacy and safety monthly for the first 3 months, then every 3 months thereafter. 5
• Monitor weight, protein intake adherence, resistance training compliance, and resolution of neck pain at each visit. 5, 1

Common Pitfalls to Avoid

• Do not discontinue tirzepatide prematurely for musculoskeletal symptoms that are likely secondary to rapid weight loss rather than direct drug toxicity. 2, 1
• Do not delay resistance training until after weight plateau; muscle is most vulnerable to loss during active weight reduction. 1
• Do not attribute all neck pain to tirzepatide without ruling out mechanical causes, nutritional deficiencies, or pre-existing cervical pathology. 3
• Most tirzepatide-related adverse events occur during dose escalation (particularly at 2.5–5 mg range), but musculoskeletal complaints may emerge at any dose due to cumulative weight loss. 1